Breaking

RBI Cuts FY27 Growth to 6.9%: What the Numbers Tell Investors PNB Q4 Results: Why ₹5,225 Cr Profit Came With NII Drop Rupee Up 5 Paise to 95.53: What the Numbers Tell Investors Pre-Market Opening: Sensex, Nifty, FII/DII & Cues Wipro’s ₹15,000 Crore Buyback: What It Tells ADR Holders “Air Cargo Demand Up 4%: What the Numbers Tell Investors The Numbers Behind India’s ₹46,000 Crore Coal Gasification Bet India-Korea CEPA: The Numbers Behind a $15.35 Bn Deficit RBI Cuts FY27 Growth to 6.9%: What the Numbers Tell Investors PNB Q4 Results: Why ₹5,225 Cr Profit Came With NII Drop Rupee Up 5 Paise to 95.53: What the Numbers Tell Investors Pre-Market Opening: Sensex, Nifty, FII/DII & Cues Wipro’s ₹15,000 Crore Buyback: What It Tells ADR Holders “Air Cargo Demand Up 4%: What the Numbers Tell Investors The Numbers Behind India’s ₹46,000 Crore Coal Gasification Bet India-Korea CEPA: The Numbers Behind a $15.35 Bn Deficit

Tag: oncology injectables

Business May 23, 2026 By PITAM GHOSH

Venus Remedies’ 1st Plerixafor Nod: What It Tells Investors.

A first-ever global approval reads as a strategic marker — yet the near-term numbers tell a far quieter story. Venus Remedies Plerixafor secured its…